A detailed history of Beacon Pointe Advisors, LLC transactions in Spdr Ser Tr Spdr S&P Pharmaceu stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 4,917 shares of XPH stock, worth $219,839. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,917
Holding current value
$219,839
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$42.71 - $48.29 $210,005 - $237,441
4,917 New
4,917 $211,000
Q2 2022

Aug 11, 2022

BUY
$38.15 - $46.44 $6,599 - $8,034
173 Added 3.73%
4,817 $202,000
Q1 2022

May 17, 2022

BUY
$41.55 - $46.61 $192,958 - $216,456
4,644 New
4,644 $210,000
Q2 2021

Aug 17, 2021

SELL
$48.16 - $53.09 $203,716 - $224,570
-4,230 Closed
0 $0
Q1 2021

May 18, 2021

BUY
$49.44 - $56.01 $209,131 - $236,922
4,230 New
4,230 $213,000

Others Institutions Holding XPH

About SPDR SER TR SPDR S&P PHARMACEU


  • Ticker XPH
  • Sector ETFs
  • Industry ETFs
More about XPH
Track This Portfolio

Track Beacon Pointe Advisors, LLC Portfolio

Follow Beacon Pointe Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.